- Home
- BLRX vs PRTS Comparison
BLRX vs PRTS Comparison
Compare BLRX & PRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLRX
- PRTS
- Stock Information
- Founded
- BLRX 2003
- PRTS 1995
- Country
- BLRX Israel
- PRTS United States
- Employees
- BLRX N/A
- PRTS N/A
- Industry
- BLRX Biotechnology: Pharmaceutical Preparations
- PRTS Auto & Home Supply Stores
- Sector
- BLRX Health Care
- PRTS Consumer Discretionary
- Exchange
- BLRX Nasdaq
- PRTS Nasdaq
- Market Cap
- BLRX 54.1M
- PRTS 48.4M
- IPO Year
- BLRX 2011
- PRTS 2007
- Fundamental
- Price
- BLRX $0.46
- PRTS $0.90
- Analyst Decision
- BLRX Strong Buy
- PRTS Buy
- Analyst Count
- BLRX 2
- PRTS 4
- Target Price
- BLRX $11.50
- PRTS $2.33
- AVG Volume (30 Days)
- BLRX 202.4K
- PRTS 406.9K
- Earning Date
- BLRX 11-18-2024
- PRTS 10-28-2024
- Dividend Yield
- BLRX N/A
- PRTS N/A
- EPS Growth
- BLRX N/A
- PRTS N/A
- EPS
- BLRX N/A
- PRTS N/A
- Revenue
- BLRX $17,048,000.00
- PRTS $633,818,000.00
- Revenue This Year
- BLRX N/A
- PRTS N/A
- Revenue Next Year
- BLRX N/A
- PRTS $2.32
- P/E Ratio
- BLRX N/A
- PRTS N/A
- Revenue Growth
- BLRX N/A
- PRTS N/A
- 52 Week Low
- BLRX $0.44
- PRTS $0.72
- 52 Week High
- BLRX $1.93
- PRTS $4.17
- Technical
- Relative Strength Index (RSI)
- BLRX 23.64
- PRTS 52.75
- Support Level
- BLRX $0.50
- PRTS $0.87
- Resistance Level
- BLRX $0.56
- PRTS $0.95
- Average True Range (ATR)
- BLRX 0.05
- PRTS 0.04
- MACD
- BLRX -0.01
- PRTS 0.00
- Stochastic Oscillator
- BLRX 10.60
- PRTS 59.00
About BLRX BioLineRx Ltd.
BioLine Rx Ltd is a commercial-stage biopharmaceutical company focused on oncology. The company's current development and commercialization pipeline consists of two clinical-stage therapeutic candidates motixafortide (BL-8040), a novel peptide for the treatment of stem-cell mobilization and solid tumors, and AGI-134, an immuno-oncology agent in development for solid tumors. In addition, the company has an off-strategy, legacy therapeutic product called BL-5010 for the treatment of skin lesions. The company has generated revenues from milestone payments under previously existing out-licensing agreements.
About PRTS CarParts.com Inc.
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. It serves as an end-to-end solution for automotive repair and maintenance resources, offering a seamless online shopping experience that empowers drivers along every part of their journey. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.